NF2 and cancer: Using the E-cadherin NF2 Hippo YAP signaling pathway as an example, E-cadherin loss-of-function causes a range of mutations in cancer, with NF2 loss-of-function mutations occurring in more than three-tenths of mesothelioma (91, 92).